Induction of TH1 and TH2 CD4+ T cell responses: The alternative approaches

被引:1238
作者
Constant, SL [1 ]
Bottomly, K [1 ]
机构
[1] YALE UNIV,SCH MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06510
关键词
Th1/Th2; cells; altered peptide ligand; antigen dose; CD28/B7; T cell priming; B7-2 COSTIMULATORY MOLECULES; INTERFERON-GAMMA PRODUCTION; ANTIGEN-PRESENTING CELLS; TCR TRANSGENIC MICE; IFN-GAMMA; IN-VIVO; MEDIATED-IMMUNITY; DENDRITIC CELLS; B-CELLS; AUTOIMMUNE ENCEPHALOMYELITIS;
D O I
10.1146/annurev.immunol.15.1.297
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T helper lymphocytes can be divided into two distinct subsets of effector cells based on their functional capabilities and the profile of cytokines they produce. The Th1 subset of CD4(+) T cells secretes cytokines usually associated viith inflammation, such as IFN-gamma and TNF and induces cell-mediated immune responses. The Th2 subset produces cytokines such as IL-4 and IL-5 that help B cells to proliferate and differentiate and is associated with humoral-type immune responses. The selective differentiation of either subset is established during priming and can be significantly influenced by a variety of factors. One of these factors, the cytokine environment, has been put forward as the major variable influencing Tn development and is already well reviewed by others. Instead, in the current review, we focus on some of the alternative approaches for skewing Th1/Th2 responses. Specifically, we discuss the effects on Th priming of (a) using altered peptide ligands as antigens, (b) varying the dose of antigen, and (c) altering costimulatory signals. The potential importance of each of these variables to influence immune responses to pathogens in vivo is discussed throughout.
引用
收藏
页码:297 / 322
页数:26
相关论文
共 102 条
[11]   Peptide analogs with different affinities for MHC alter the cytokine profile of T helper cells [J].
Chaturvedi, P ;
Yu, Q ;
Southwood, S ;
Sette, A ;
Singh, B .
INTERNATIONAL IMMUNOLOGY, 1996, 8 (05) :745-755
[12]   IN-VITRO INDUCTION OF T-CELL ANERGY BY BLOCKING B7 AND EARLY T-CELL COSTIMULATORY MOLECULE ETC-1 B7-2 [J].
CHEN, CY ;
NABAVI, N .
IMMUNITY, 1994, 1 (02) :147-154
[13]   COSTIMULATION OF ANTITUMOR IMMUNITY BY THE B7 COUNTERRECEPTOR FOR THE LYMPHOCYTE-T MOLECULES CD28 AND CTLA-4 [J].
CHEN, LP ;
ASHE, S ;
BRADY, WA ;
HELLSTROM, I ;
HELLSTROM, KE ;
LEDBETTER, JA ;
MCGOWAN, P ;
LINSLEY, PS .
CELL, 1992, 71 (07) :1093-1102
[14]  
CHER DJ, 1987, J IMMUNOL, V138, P3688
[15]   THE ROLE OF HELPER T-CELL PRODUCTS IN MOUSE B-CELL DIFFERENTIATION AND ISOTYPE REGULATION [J].
COFFMAN, RL ;
SEYMOUR, BWP ;
LEBMAN, DA ;
HIRAKI, DD ;
CHRISTIANSEN, JA ;
SHRADER, B ;
CHERWINSKI, HM ;
SAVELKOUL, HFJ ;
FINKELMAN, FD ;
BOND, MW ;
MOSMANN, TR .
IMMUNOLOGICAL REVIEWS, 1988, 102 :5-28
[16]  
CONSTANT S, 1995, J IMMUNOL, V154, P4915
[17]  
CONSTANT S, 1995, J IMMUNOL, V155, P3734
[18]   ARE PRIMED CD4(+) T-LYMPHOCYTES DIFFERENT FROM UNPRIMED CELLS [J].
CONSTANT, S ;
ZAIN, M ;
WEST, J ;
PASQUALINI, T ;
RANNEY, P ;
BOTTOMLY, K .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (05) :1073-1079
[19]   EXTENT OF T-CELL RECEPTOR LIGATION CAN DETERMINE THE FUNCTIONAL-DIFFERENTIATION OF NAIVE CD4(+) T-CELLS [J].
CONSTANT, S ;
PFEIFFER, C ;
WOODARD, A ;
PASQUALINI, T ;
BOTTOMLY, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05) :1591-1596
[20]  
CORRY DB, 1994, J IMMUNOL, V153, P4142